Leadership Overhaul: Astec LifeSciences Limited Announces Key Director Changes
Astec LifeSciences Limited announced significant leadership changes following its Board of Directors meeting held on April 13, 2026. The meeting saw the retirement of the Chairperson and the appointment of multiple key directors, reshaping the company's board structure.The board meeting detailed several transitions, beginning with the retirement of Mr. Nadir Godrej from his roles as Chairperson and Director, effective from the close of business hours on April 13, 2026. The Board placed on record its appreciation for Mr. Godrej's leadership during his tenure.
Key Director Appointments and Changes
The Board approved four major changes concerning director roles:1. Appointment of Mr. Vishal Sharma as Chairperson
The company approved the appointment of Mr. Vishal Sharma as an Additional Director (Non-Executive, Non-Independent) and Chairperson of the Board of Directors, effective from the close of business hours on April 13, 2026. Mr. Sharma is an Executive Director & Chief Executive Officer (Chemicals) of Godrej Industries Limited, the Ultimate Holding Company of Astec LifeSciences Limited.
2. Appointment of Mr. Mathew Eipe
Mr. Mathew Eipe was appointed as an Additional, Non-Executive, Independent Director. This appointment is for a term spanning from April 13, 2026, to June 6, 2027, subject to the approval of the Shareholders. Mr. Eipe is an Independent Director of Godrej Industries Limited.
3. Appointment of Mr. Arijit Mukherjee
Mr. Arijit Mukherjee was appointed as an Additional Director and Executive Director, designated as Executive Director & Chief Operating Officer. This role is set for a three-year term, effective from April 13, 2026, to April 12, 2029, subject to shareholder approval. Mr. Mukherjee currently serves as the Chief Operating Officer of the Company.
4. Resignation and Reappointment of Mr. Burjis N. Godrej
Mr. Burjis N. Godrej resigned from the post of Managing Director of the Company with immediate effect. His resignation, while expressing willingness to continue on the board, was attributed to his desire for deeper and broader involvement in Godrej Agrovet Limited, the parent company. Concurrently, the Board approved his appointment as an Additional Director (Non-Executive, Non-Independent), effective from the close of business hours on April 13, 2026.
Profiles of New and Continuing Directors
| Director Name | Role/Designation | Key Experience Highlights |
|---|---|---|
| Mr. Vishal Sharma | Additional Director (Non-Executive, Non-Independent) & Chairperson | Brings 30 years of business experience, primarily in Specialty and Process Chemicals. Previously spent 10 years with Ecolab Inc. and 12 years with Diversey Inc. |
| Mr. Mathew Eipe | Additional, Non-Executive, Independent Director | Independent Director of Godrej Industries Limited. Joined Godrej Soaps Limited as a management trainee in 1977, leading the successful turnaround and integration of GGIC. |
| Mr. Arijit Mukherjee | Additional Director & Executive Director / Chief Operating Officer | Has over 20 years of experience in the Agri Inputs business. Currently oversees manufacturing and B2B/CDMO for Astec LifeSciences Limited. |
| Mr. Burjis N. Godrej | Additional Director (Non-Executive) | Has been an Executive Director of Godrej Agrovet Limited since 2022. Previously served as Managing Director of Astec LifeSciences Limited (2025-2026). |
Board Composition
Following these transitions, the Board of Directors composition will comprise a total of 10 Directors. Of these, five directors will be Independent Directors, and the remaining five directors will be Non-Independent Directors.ASTEC Stock Price Movement
Shares of Astec LifeSciences Limited today slipped by 3.71% to settle at ₹635.65. The stock traded on a volume of 373,976 shares, finishing near its intraday low of ₹630.35.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.